abc biopply ag

abc biopply is a CRO with its own specifically designed proprietary 3D cell culture platform 3D CoSeedis™.

abc biopply’s proprietary technology creates hundreds of miniature versions of patient organs in a laboratory setting, using both healthy and diseased tissues. Their innovative models bridge the gap in predictability between the lab and the clinic.

The company offers a comprehensive portfolio of validated service packages based on the proprietary 3D CoSeedis in chip communication technology™. Utilizing 3D CoSeedis humanized multi-organoid models™, as well as traditional monolayer models, they specialize in assay endpoints useful for drug discovery and pharmaceutical development.